BULATO, CRISTIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.747
EU - Europa 299
AS - Asia 158
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 3
AF - Africa 1
OC - Oceania 1
Totale 3.215
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.741
CN - Cina 105
IT - Italia 91
SE - Svezia 55
FI - Finlandia 51
VN - Vietnam 38
DE - Germania 26
GB - Regno Unito 26
UA - Ucraina 12
IN - India 11
IE - Irlanda 10
NL - Olanda 10
EU - Europa 5
MX - Messico 5
ES - Italia 4
TW - Taiwan 4
BE - Belgio 3
BR - Brasile 3
CH - Svizzera 3
FR - Francia 2
RO - Romania 2
A1 - Anonimo 1
AU - Australia 1
CA - Canada 1
EE - Estonia 1
EG - Egitto 1
HR - Croazia 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 3.215
Salva come PNG Salva come JPEG
Città #
Fairfield 491
Woodbridge 335
Chandler 286
Ashburn 214
Seattle 191
Houston 190
Ann Arbor 177
Cambridge 176
Wilmington 135
San Diego 61
Princeton 49
Jacksonville 44
Des Moines 43
Dong Ket 37
Medford 37
Beijing 36
Padova 35
Helsinki 32
Roxbury 24
Boardman 20
Nanjing 13
London 12
Milan 9
New York 9
Norwalk 8
Dublin 7
Hebei 7
Guangzhou 6
Nanchang 6
Pune 6
Falls Church 5
Los Angeles 5
Redwood City 5
Kilburn 4
Kunming 4
Taipei 4
Chiampo 3
De Zilk 3
Detroit 3
Jinan 3
Kharkiv 3
Mexico 3
Naples 3
Shanghai 3
Shenyang 3
Tianjin 3
Washington 3
Bassano Del Grappa 2
Bologna 2
Cardano al Campo 2
Chicago 2
Gurgaon 2
Hefei 2
Jiaxing 2
Lanzhou 2
Nürnberg 2
Ogden 2
Piacenza 2
Santa Ursula 2
Segovia 2
Taizhou 2
Waanrode 2
Adliswil 1
Atlanta 1
Basel 1
Berlin 1
Bern 1
Borås 1
Bratislava 1
Brussels 1
Cairo 1
Changsha 1
Chiswick 1
Cona 1
Delhi 1
Denver 1
Dubbo 1
Edinburgh 1
Falkenstein 1
Foggia 1
Fortaleza 1
Groningen 1
Hanoi 1
Iasi 1
Islington 1
Lappeenranta 1
Las Vegas 1
Madrid 1
Noves 1
Orange 1
Portland 1
Ribeirão Prêto 1
Riese Pio X 1
Rockville 1
Rome 1
Selvazzano Dentro 1
Stockholm 1
São Paulo 1
Tallinn 1
Tappahannock 1
Totale 2.824
Salva come PNG Salva come JPEG
Nome #
The thioredoxin specificity of Drosophila GPx: A paradigm for a peroxiredoxin-like mechanism of many glutathione peroxidases 162
Dynamics of circulating microparticles in obesity after weight loss 143
Changes in plasma circulating microvesicles in patients with HCV‐related cirrhosis after treatment with direct‐acting antivirals 121
X-linked thrombophilia with a mutant factor IX (factor IX Padua). 116
Whole blood rotation thromboelastometry (ROTEM(®)) in nine severe factor V deficient patients and evaluation of the role of intraplatelets factor V. 109
New prothrombin mutation (Arg596Trp, Prothrombin Padua 2) associated with venous thromboembolism 105
Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S 105
Factor IX activity/antigen ratio and the risk of first unprovoked venous thromboembolism. 105
Effect of mercury on selenium utilization and selenoperoxidase activity in LNCaP cells 103
Platelet factor V levels in moderate to severe congenital factor V deficiency. 103
Studies on coagulation incompatibilities for xenotransplantation. 101
Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. 99
Effects of long-term administration of recombinant human protein C in xenografted primates. 98
Characterization of an apparently synonymous F5 mutation causing aberrant splicing and factor V deficiency 94
Genetic modulation of the FV(Leiden)/normal FV ratio and risk of venous thrombosis in factor V Leiden heterozygotes. 88
Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct acting antivirals 88
Circulating microparticles in pregnant patients with primary anti-phospholipid syndrome: an exploratory study 86
“In vitro” correction of the severe factor V deficiency-related coagulopathy by a novel plasma-derived factor V concentrate 86
Thromboelastographic evaluation of coagulative profiles in pig-to-monkey kidney xenotransplantation. 84
Peculiar laboratory phenotype/ genotype relationship due to compound inherited protein C defects in a child with severe venous thromboembolism 83
Reference values for thromboelastometry (ROTEM®) in cynomolgus monkeys (Macaca fascicularis). 80
Acute Kidney Injury in Decompensated Cirrhosis Is Associated With Both Hypo-coagulable and Hyper-coagulable Features 79
Identification of a novel frameshift mutation causing a premature stop codon in a young Nigerian man with type I antithrombin deficiency. 77
Thromboelastometry profiles after “in vitro” addition of a new plasma-derived factor V concentrate to whole blood from parahaemophilia patients 77
Acute kidney injury is associated with increased levels of circulating microvesicles in patients with decompensated cirrhosis 68
Endocytosis of exogenous factor V by ex-vivo differentiated megakaryocytes from patients with severe parahaemophilia 67
Partial F8 gene duplication (Factor VIII Padua) associated with high factor VIII levels and familial thrombophilia 65
Thrombin generation in patients with COVID-19 with and without thromboprophylaxis 60
Characterisation of the serotonin efflux induced by cytosolic Ca2+ and Na+ concentration increase in human platelets 54
Determinants of increased thrombotic tendency in NASH cirrhosis: not there yet! 54
Whole blood coagulation assessment using novel rotational thromboelastometry (ROTEM-R) in seen naive cynomologus monkeys 53
Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study 53
PTPepsilon has a critical role in signaling transduction pathways and phosphoprotein network topology in red cells. 52
Thrombin generation and thromboelastometry in monitoring the in-vitro reversal of warfarin: A comparison between 3-factor and 4-factor prothrombin complex concentrates 48
Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure 47
More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC 37
Influence of hepatocellular carcinoma on platelet aggregation in cirrhosis 36
Longitudinal Trend of Plasma Concentrations of Extracellular Vesicles in Patients Hospitalized for COVID-19 30
Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections 30
Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study 28
Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study 23
Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and death 20
Protein C or Protein S deficiency associates with paradoxically impaired platelet-dependent thrombus and fibrin formation under flow 10
Whole blood thrombin generation shows a significant hypo-coagulable state in patients with decompensated cirrhosis 8
Severity of systemic inflammation is the main predictor of ACLF and bleeding in patients with acutely decompensated cirrhosis 7
In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency 6
Crucial roles of red blood cells and platelets in whole blood thrombin generation 5
von Willebrand factor in hospitalized patients with acute decompensation of cirrhosis is increased but not associated with development of ACLF 5
von Willebrand factor does not predict short-term mortality in ACLF 1
Totale 3.259
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.573
article - articoli 12.573
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.146
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019178 0 0 0 0 0 0 0 0 0 0 104 74
2019/2020653 67 34 14 83 71 45 69 79 80 53 29 29
2020/2021599 12 45 39 56 46 28 28 52 74 66 67 86
2021/2022678 40 72 74 34 32 68 39 60 33 28 65 133
2022/2023539 90 73 7 77 84 80 6 37 59 3 19 4
2023/2024242 10 46 35 35 24 50 20 3 3 16 0 0
Totale 3.259